Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.01.16.633344

Trends and characteristics of multidrug resistant MRSA in Norway 2008-2020

Abstract

Infections caused by multidrug-resistant (MDR) bacteria are recognized as a critical One Health concern which poses a significant threat to public health, leading to increased morbidity and mortality across both high- and low-income countries. In this study, we investigated the epidemiology and molecular mechanisms of multidrug-resistant methicillin-resistant Staphylococcus aureus (MDR-MRSA) strains identified in Norway from 2008 to 2020, in order to gain a better understanding of the evolution and dissemination of multidrug resistance in S. aureus. A total of 452 MDR-MRSA strains isolated from 429 individuals were analyzed from a dataset of 23,412 MRSA strains. Methods included epidemiological characterization, antimicrobial susceptibility testing (AST) and genetic analysis of a selection of strains using nanopore sequencing to identify antimicrobial resistance (AMR) genes and mutations, as well as their location on plasmids, SCCmec and other mobile genetic elements (MGEs). The study revealed an overall increasing trend in MDR-MRSA strains, with healthcare-associated strains being more prevalent among MDR-MRSA compared to the overall MRSA population. Significant heterogeneity in spa-types and clonal complexes exhibiting multidrug resistance was observed, with high resistance rates against multiple antibiotic groups, particularly erythromycin, ciprofloxacin/norfloxacin, tetracycline, gentamicin, and clindamycin in addition to cefoxitin. The predominant MDR-MRSA clones included t1476/CC8, t127/CC1, t189/CC188 and t030, t037/CC239. A broad range of AMR genes and mutations were detected, linked to a wide variety of MGEs, highlighting the complex mechanisms of resistance development and dissemination within the MRSA population. This study highlights the rising challenge posed by MDR-MRSA strains, and reveals the multifactorial nature of AMR in S. aureus, thus emphasizing the importance of continued surveillance, antibiotic stewardship and infection control measures, as well as global cooperation, in order to combat the spread of these multidrug-resistant pathogens. Author SummaryIn our study, we explored the landscape of multidrug-resistant methicillin-resistant Staphylococcus aureus (MDR-MRSA) in Norway from 2008 to 2020. This research is possible because it draws on a robust national surveillance system that has been active for over a decade, aimed at preventing the establishment of these dangerous pathogens in our healthcare facilities. While the overall incidence of MDR-MRSA was relatively low, we noticed an upward trend in the number of these resistant strains over time. This pattern, along with shifts in the molecular profiles of the strains, suggests that certain MDR-MRSA clones have become well-established and are spreading globally. One of the most important findings was that the majority of MDR-MRSA strains were acquired abroad. This indicates that international travel and migration are significant contributors to the spread of these resistant strains, particularly from regions like Asia and Africa. This underscores the necessity for global collaboration in surveillance and antibiotic stewardship to combat the threat posed by these pathogens. Additionally, we found that a high proportion of MDR-MRSA strains were associated with healthcare settings, primarily isolated from patients during hospital admissions. This is concerning, as it suggests that the most resistant strains are often found in hospitals, where vulnerable patients are at risk. The high antibiotic exposures in these environments likely contributes to the selection and spread of these resistant clones. Interestingly, we discovered that many of the MDR-MRSA strains were detected in asymptomatic carriers rather than in clinical infections. This could be due to the strains being acquired abroad and subsequently identified through routine screening in healthcare settings. The overall potential implications for public health are however significant, especially since the resistance profiles of these strains can severely limit treatment options. By utilizing advanced nanopore sequencing technology, we were able to delve deeper into the genetic elements responsible for antibiotic resistance, highlighting the extensive heterogeneity of resistance mechanisms among the MDR-MRSA strains. We found that resistance genes are primarily located on plasmids and other mobile genetic elements, which enhances their potential for spread among different strains. This complexity of resistance mechanisms and the adaptive strategies employed by MRSA highlight the ongoing battle against antibiotic resistance. In conclusion, our study sheds light on the evolving landscape of MDR-MRSA, emphasizing the need for continued vigilance and coordinated efforts to mitigate the spread of these resistant strains.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ronning, T. G., Enger, H. G., Afset, J. E., As, C. G.. 2025-01-17. Trends and characteristics of multidrug resistant MRSA in Norway 2008-2020. https://doi.org/10.1101/2025.01.16.633344

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A population-scale landscape of the subgingival microbiome reveals divergent routes to periodontal dysbiosis

Periodontitis is an archetypical mucosal inflammatory disease in which microbiome dysbiosis at the tooth-epithelial interface interacts with host genetic and behavioral risk factors to drive immune-mediated tissue destruction. Although subgingival microbiome compositional shifts are thought to parallel disease severity, microbiome variation at the population-level and its relationship to periodontal clinical phenotypes and disease-modifying factors remain poorly defined. Here, we use unsupervised manifold learning to map the compositional landscape of the subgingival microbiome in 1,355 adults spanning periodontal health to severe periodontitis. We identified eight latent microbiome states organized along a branching continuum from eubiosis to dysbiosis. An intermediate microbial configuration marked ecological destabilization and bifurcation into two distinct periodontitis-associated dysbiotic trajectories, distinguished by links to gingival inflammation and smoking. Although the microbiome trajectories broadly tracked periodontal destruction, a minority of individuals showed discordant microbiome-clinical phenotypes, with some individuals with periodontitis retaining otherwise eubiotic microbiomes enriched for low-abundance pathobionts, while some cases of health or mild disease had highly dysbiotic communities, suggesting distinct host susceptibility. Together, these findings define a population-scale ecological landscape of the subgingival microbiome, reveal divergent trajectories to periodontal dysbiosis, and highlight heterogeneity in the relationship between microbial community structure and clinical disease expression.

microbiology↗

Beta-lactam enhancement against methicillin-resistant Staphylococcus aureus by cell wall blockade is autolysis-dependent: a butyrolactone derivative as case in point

Methicillin-resistant Staphylococcus aureus (MRSA) is non-susceptible to beta-lactams. Blockade of cell wall biosynthesis is a potential target for beta-lactam enhancement but requires further investigation. A butyrolactone derivative enhanced beta-lactams against MRSA strains by reducing the availability of D-Ala-D-Ala. Unlike D-cycloserine, it did not inhibit D-Ala-D-Ala ligase (Ddl). Nor did it show an additive or synergistic effect when combined with cycloserine, indicating a unique mechanism for blocking cell wall precursor production that does not involve the traditional Lipid II pathway. Notably, beta-lactam potentiation by our chemical or D-cycloserine was highly dependent on the intrinsic autolytic ability of the tested MRSA strains. Strains that resisted lysis upon Triton X-100 exposure showed a minimal increase in beta-lactam susceptibility, whereas highly autolytic strains showed significant changes in their beta-lactam MICs. We have thus identified autolytic ability as the Achilles Heel in the strategy of targeting cell wall biosynthesis for beta-lactam potentiation.

microbiology↗

Rapid and largely reversible shifts in the canine fecal metabolome during dietary change

Diet can rapidly change the fecal metabolome, but less is known about recovery after the original diet is restored. We used untargeted UPLC-MS metabolomics to analyze 72 fecal samples from nine Pumi dogs during an owner-managed switch from dry food to raw food and back to dry food. Diet phase accounted for a large proportion of variation in both ionization modes. More than 13,000 LC-MS features changed at the first sampling point after the switch to raw food, with a similarly large response after return to dry food. Among features significant in both comparisons, more than 99% changed in opposite directions. At the final sampling point, no positive-mode (ESI+) features and only 13 negative-mode (ESI-) features differed from the second dry-food baseline under the same threshold. BARF-associated patterns persisted in analyses excluding individual dogs and in pedigree-adjusted candidate models, although individual feature effects depended on normalization. Putative metabolites from several biochemical classes differed in their response and recovery. The fecal metabolome therefore changed rapidly and returned largely toward baseline, with differences among dogs.

microbiology↗